Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level

被引：0
|
作者：
N. M. Atallah
M. Alsaleem
M. S. Toss
N. P. Mongan
E. Rakha
机构：
[1] the University of Nottingham and Nottingham University Hospitals NHS Trust,Division of Cancer and Stem Cells, School of Medicine
[2] Menoufia University,Department of Pathology, Faculty of Medicine
[3] Qassim University,Unit of Scientific Research, Applied College
[4] Sheffield Teaching Hospitals NHS Foundation Trust,Histopathology Department, Royal Hallamshire Hospital
[5] University of Nottingham,School of Veterinary Medicine and Sciences
[6] Weill Cornell Medicine,Department of Pharmacology
来源：
British Journal of Cancer | 2023年 / 129卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1692 / 1705
页数：13
相关论文
共 50 条
  • [1] Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
    Atallah, N. M.
    Alsaleem, M.
    Toss, M. S.
    Mongan, N. P.
    Rakha, E.
    BRITISH JOURNAL OF CANCER, 2023, 129 (10) : 1692 - 1705
  • [2] Differential response of HER2 positive breast cancer based on HER2 protein expression level
    Atallah, N. M.
    Toss, M. S.
    Al Saleem, M.
    Green, A. R.
    Mongan, N. P.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2023, 261 : S9 - S9
  • [3] The perspective of anti-HER2 therapy for HER2 positive breast cancer
    Iwata, Hiroji
    ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
  • [4] Pathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer
    Chen, Hai-Long
    Chen, Qiang
    Deng, Yong-Chuan
    MEDICINE, 2021, 100 (44)
  • [5] Prediction of HER2 positive breast cancer patients' response to anti-HER2 therapy using mRNA level
    Atallah, N.
    Makhlouf, S.
    Li, X. M.
    Zhangy, Y.
    Rakha, E.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 114 - 114
  • [6] HER2Δ16 expression in HER2-positive breast cancer
    De Yao, Jocelyn Torres
    Sun, Danyu
    Galehouse, Donna
    Shorten, Scott
    Haller, Nairmeen
    Rehmus, Esther Hoogland
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] HER2Δ16 expression in HER2-positive breast cancer
    De Yao, Jocelyn Torres
    Sun, Danyu
    Galehouse, Donna
    Shorten, Scott
    Haller, Nairmeen Awad
    Rehmus, Esther Hoogland
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [8] HER2 Amplification Level and Focal/Broad Region Size as Predictors of Treatment Response in Neoadjuvant Chemotherapy and Anti-HER2 Therapy for HER2-Positive Breast Cancer
    Liao, Ning
    Zhang, Guochun
    Lv, Xinze
    Li, Kai
    Hou, Ting
    Zhang, Zhou
    CANCER RESEARCH, 2024, 84 (09)
  • [9] Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients
    You, Ji Young
    Park, Kyoung Hwa
    Lee, Eun Sook
    Kwon, Youngmee
    Kim, Kyoung Tae
    Nam, Seungyoon
    Kim, Dong Hee
    Bae, Jeoung Won
    CANCER CONTROL, 2023, 30
  • [10] Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients
    You, Ji Young
    Park, Kyoung Hwa
    Lee, Eun Sook
    Kwon, Youngmee
    Kim, Kyoung Tae
    Nam, Seungyoon
    Kim, Dong Hee
    Bae, Jeoung Won
    CANCER CONTROL, 2022, 29
12345